» Articles » PMID: 34336857

Physiological Functions of Mcl-1: Insights From Genetic Mouse Models

Overview
Specialty Cell Biology
Date 2021 Aug 2
PMID 34336857
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

The ability to regulate the survival and death of a cell is paramount throughout the lifespan of a multicellular organism. Apoptosis, a main physiological form of programmed cell death, is regulated by the Bcl-2 family proteins that are either pro-apoptotic or pro-survival. The functions of distinct Bcl-2 family members are largely unmasked by genetically engineered murine models. is one of the two Bcl-2 like pro-survival genes whose germline deletion causes embryonic lethality in mice. Its requisite for the survival of a broad range of cell types has been further unraveled by using conditional and inducible deletion murine model systems in different tissues or cell lineages and at distinct developmental stages. Moreover, genetic mouse cancer models have also demonstrated that is essential for the survival of multiple tumor types. The locus is commonly amplified across various cancer types in humans. Small molecule inhibitors with high affinity and specificity to human MCL-1 have been developed and explored for the treatment of certain cancers. To facilitate the pre-clinical studies of MCL-1 in cancer and other diseases, transgenic mouse models over-expressing human as well as humanized mouse models have been recently engineered. This review discusses the current advances in understanding the physiological roles of Mcl-1 based on studies using genetic murine models and its critical implications in pathology and treatment of human diseases.

Citing Articles

Tipping the balance of cell death: alternative splicing as a source of MCL-1S in cancer.

Hartman M Cell Death Dis. 2024; 15(12):917.

PMID: 39695189 PMC: 11655658. DOI: 10.1038/s41419-024-07307-z.


The Role of Bcl-2 Family Proteins and Sorafenib Resistance in Hepatocellular Carcinoma.

de Melo Silva A, de Melo Gama J, de Oliveira S Int J Cell Biol. 2024; 2024:4972523.

PMID: 39188653 PMC: 11347034. DOI: 10.1155/2024/4972523.


Evaluation of MCL-1 as a prognostic factor in canine mammary gland tumors.

Cho J, Chung H, Lee S, Kim W PLoS One. 2024; 19(7):e0306398.

PMID: 39012900 PMC: 11251587. DOI: 10.1371/journal.pone.0306398.


NF-kB affects migration of vascular smooth muscle cells after treatment with heparin and ibrutinib.

Shokri N, Ghasempour G, Soleimani A, Elahimanesh M, Najafi M Biochem Biophys Rep. 2024; 38:101685.

PMID: 38524279 PMC: 10957380. DOI: 10.1016/j.bbrep.2024.101685.


Selective MCL-1 inhibitor ABBV-467 is efficacious in tumor models but is associated with cardiac troponin increases in patients.

Yuda J, Will C, Phillips D, Abraham L, Alvey C, Avigdor A Commun Med (Lond). 2023; 3(1):154.

PMID: 37880389 PMC: 10600239. DOI: 10.1038/s43856-023-00380-z.


References
1.
Anstee N, Vandenberg C, Campbell K, Hughes P, OReilly L, Cory S . Overexpression of Mcl-1 exacerbates lymphocyte accumulation and autoimmune kidney disease in lpr mice. Cell Death Differ. 2016; 24(3):397-408. PMC: 5344201. DOI: 10.1038/cdd.2016.125. View

2.
Min B . Deleting Mcl-1 in mast cells: getting 2 birds with 1 stone. Blood. 2011; 118(26):6729-30. DOI: 10.1182/blood-2011-10-386565. View

3.
Grabow S, Kelly G, Delbridge A, Kelly P, Bouillet P, Adams J . Critical B-lymphoid cell intrinsic role of endogenous MCL-1 in c-MYC-induced lymphomagenesis. Cell Death Dis. 2016; 7:e2132. PMC: 4823944. DOI: 10.1038/cddis.2016.43. View

4.
Reynolds J, Yang T, Qian L, Jenkinson J, Zhou P, Eastman A . Mcl-1, a member of the Bcl-2 family, delays apoptosis induced by c-Myc overexpression in Chinese hamster ovary cells. Cancer Res. 1994; 54(24):6348-52. View

5.
Chen L, Willis S, Wei A, Smith B, Fletcher J, Hinds M . Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol Cell. 2005; 17(3):393-403. DOI: 10.1016/j.molcel.2004.12.030. View